Your browser doesn't support javascript.
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.
Parker, Robert; Partridge, Thomas; Wormald, Catherine; Kawahara, Rebeca; Stalls, Victoria; Aggelakopoulou, Maria; Parker, Jimmy; Powell Doherty, Rebecca; Ariosa Morejon, Yoanna; Lee, Esther; Saunders, Kevin; Haynes, Barton F; Acharya, Priyamvada; Thaysen-Andersen, Morten; Borrow, Persephone; Ternette, Nicola.
  • Parker R; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK. Electronic address: robert.parker@ndm.ox.ac.uk.
  • Partridge T; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX37FZ, UK.
  • Wormald C; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX37FZ, UK.
  • Kawahara R; Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia.
  • Stalls V; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Aggelakopoulou M; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX37FZ, UK.
  • Parker J; Wellbeing Software, Hamilton Court, Oakham Business Park, Mansfield NG185FB, UK.
  • Powell Doherty R; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Translational Gastroenterology Unit, Oxford OX3 9DU, UK.
  • Ariosa Morejon Y; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; The Kennedy Institute of Rheumatology, Oxford OX3 7FY, UK.
  • Lee E; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Saunders K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Acharya P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.
  • Thaysen-Andersen M; Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia; Biomolecular Discovery Research Centre, Macquarie University, Sydney, NSW 2109, Australia.
  • Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX37FZ, UK. Electronic address: persephone.borrow@ndm.ox.ac.uk.
  • Ternette N; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK. Electronic address: nicola.ternette@ndm.ox.ac.uk.
Cell Rep ; 35(8): 109179, 2021 05 25.
Article in English | MEDLINE | ID: covidwho-1230394
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Understanding and eliciting protective immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent priority. To facilitate these objectives, we profile the repertoire of human leukocyte antigen class II (HLA-II)-bound peptides presented by HLA-DR diverse monocyte-derived dendritic cells pulsed with SARS-CoV-2 spike (S) protein. We identify 209 unique HLA-II-bound peptide sequences, many forming nested sets, which map to sites throughout S including glycosylated regions. Comparison of the glycosylation profile of the S protein to that of the HLA-II-bound S peptides reveals substantial trimming of glycan residues on the latter, likely induced during antigen processing. Our data also highlight the receptor-binding motif in S1 as a HLA-DR-binding peptide-rich region and identify S2-derived peptides with potential for targeting by cross-protective vaccine-elicited responses. Results from this study will aid analysis of CD4+ T cell responses in infected individuals and vaccine recipients and have application in next-generation vaccine design.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptides / Dendritic Cells / Histocompatibility Antigens Class II / Spike Glycoprotein, Coronavirus / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Cell Rep Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptides / Dendritic Cells / Histocompatibility Antigens Class II / Spike Glycoprotein, Coronavirus / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Cell Rep Year: 2021 Document Type: Article